Literature DB >> 20122811

Quantitative determination of flavonoids and cycloartanol glycosides from aerial parts of Sutherlandia frutescens (L.) R. BR. by using LC-UV/ELSD methods and confirmation by using LC-MS method.

Bharathi Avula1, Yan-Hong Wang, Troy J Smillie, Xiang Fu, Xing Cong Li, Wilfred Mabusela, James Syce, Quinton Johnson, William Folk, Ikhlas A Khan.   

Abstract

This paper describes the first analytical method for the determination of four flavonoids (sutherlandins A-D) and four cycloartanol glycosides (sutherlandiosides A-D) from the aerial parts of Sutherlandia frutescens (L.) R. Br. A separation by HPLC was achieved by using a reversed phase (RP-18) column, PDA with ELS detection, and a water/acetonitrile gradient as the mobile phase. The wavelength used for quantification of four flavonoids with the diode array detector was 260 nm. Owing to their low UV absorption, the cycloartanol glycosides were detected by evaporative light scattering. The method was validated for linearity, repeatability, limits of detection (LOD) and limits of quantification (LOQ). The limits of detection and limits of quantification of eight compounds were found to be in the range from 0.1 to 7.5 microg/mL and 0.5 to 25 microg/mL, respectively. The analysis of products showed considerable variation of 1.099-5.224 mg/average weight for the major compound, sutherlandioside B. The eight compounds in plant sample and products of S. frutescens were further confirmed by LC-ESI-TOF. This method involved the use of the [M+H](+) and [M+Na](+) ions in the positive ion mode with extractive ion monitoring (EIM). Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122811      PMCID: PMC3437656          DOI: 10.1016/j.jpba.2010.01.010

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Impact of African herbal medicines on antiretroviral metabolism.

Authors:  Edward Mills; Brian C Foster; Rolf van Heeswijk; Elizabeth Phillips; Kumanan Wilson; Blair Leonard; Kazuhiro Kosuge; Isadore Kanfer
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

2.  Cycloartane glycosides from Sutherlandia frutescens.

Authors:  Xiang Fu; Xing-Cong Li; Troy J Smillie; Paulo Carvalho; Wilfred Mabusela; James Syce; Quinton Johnson; William Folk; Mitchell A Avery; Ikhlas A Khan
Journal:  J Nat Prod       Date:  2008-09-23       Impact factor: 4.050

3.  Influence of Sutherlandia frutescens extracts on cell numbers, morphology and gene expression in MCF-7 cells.

Authors:  B A Stander; S Marais; T J Steynberg; D Theron; F Joubert; C Albrecht; A M Joubert
Journal:  J Ethnopharmacol       Date:  2007-03-14       Impact factor: 4.360

4.  Anticonvulsant property of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract.

Authors:  John A O Ojewole
Journal:  Brain Res Bull       Date:  2007-09-06       Impact factor: 4.077

5.  Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract.

Authors:  J A O Ojewole
Journal:  Methods Find Exp Clin Pharmacol       Date:  2004 Jul-Aug

6.  Flavonol glycosides from the south African medicinal plant Sutherlandia frutescens.

Authors:  Xiang Fu; Xing-Cong Li; Yan-Hong Wang; Bharathi Avula; Troy J Smillie; Wilfred Mabusela; James Syce; Quinton Johnson; William Folk; Ikhlas A Khan
Journal:  Planta Med       Date:  2009-08-10       Impact factor: 3.352

7.  Impact of traditional medicinal plant extracts on antiretroviral drug absorption.

Authors:  L Brown; O Heyneke; D Brown; J P H van Wyk; J H Hamman
Journal:  J Ethnopharmacol       Date:  2008-07-02       Impact factor: 4.360

Review 8.  African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology.

Authors:  Edward Mills; Curtis Cooper; Dugald Seely; Izzy Kanfer
Journal:  Nutr J       Date:  2005-05-31       Impact factor: 3.271

  8 in total
  11 in total

1.  Isolation of sutherlandins A, B, C and D from Sutherlandia frutescens (L.) R. Br. by counter-current chromatography using spiral tubing support rotors.

Authors:  Cuiping Chen; William R Folk; Rodrigo Lazo-Portugal; Thomas M Finn; Martha Knight
Journal:  J Chromatogr A       Date:  2017-05-22       Impact factor: 4.759

2.  Isolation of Sutherlandioside B from Sutherlandia frutescens by Spiral Countercurrent Chromatography.

Authors:  Korey J Brownstein; George E Rottinghaus; Martha Knight; Yoichiro Ito; William Folk
Journal:  J Liq Chromatogr Relat Technol       Date:  2015       Impact factor: 1.312

3.  Immuno-stimulatory activity of a polysaccharide-enriched fraction of Sutherlandia frutescens occurs by the toll-like receptor-4 signaling pathway.

Authors:  Wei Lei; Jimmy D Browning; Peggy A Eichen; Chi-Hua Lu; Valeri V Mossine; George E Rottinghaus; William R Folk; Grace Y Sun; Dennis B Lubahn; Kevin L Fritsche
Journal:  J Ethnopharmacol       Date:  2015-06-18       Impact factor: 4.360

4.  Comparison of the selected secondary metabolite content present in the cancer-bush Lessertia (Sutherlandia) frutescens L. Extracts.

Authors:  Shakira Shaik; Nisha Singh; Ashley Nicholas
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

5.  Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages.

Authors:  Wei Lei; Jimmy D Browning; Peggy A Eichen; Korey J Brownstein; William R Folk; Grace Y Sun; Dennis B Lubahn; George E Rottinghaus; Kevin L Fritsche
Journal:  Int Immunopharmacol       Date:  2015-11-12       Impact factor: 4.932

6.  Inhibition of Gli/hedgehog signaling in prostate cancer cells by "cancer bush" Sutherlandia frutescens extract.

Authors:  Hui Lin; Glenn A Jackson; Yuan Lu; Sara K Drenkhahn; Korey J Brownstein; Nicholas J Starkey; William R Lamberson; Kevin L Fritsche; Valeri V Mossine; Cynthia L Besch-Williford; William R Folk; Yong Zhang; Dennis B Lubahn
Journal:  Cell Biol Int       Date:  2015-10-06       Impact factor: 3.612

7.  Effect of the African Traditional Medicine, Sutherlandia frutescens, on the Bioavailability of the Antiretroviral Protease Inhibitor, Atazanavir.

Authors:  Adrienne C Müller; Michael F Skinner; Isadore Kanfer
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-12       Impact factor: 2.629

8.  Evaluation of phytochemical composition, toxicity in Drosophila melanogaster and effects on antibiotics modulation of Plathymenia reticulata Benth extract.

Authors:  E M Luna; T S Freitas; F F Campina; M S Costa; J E Rocha; R P Cruz; D L Sena Júnior; Z S Silveira; N S Macedo; J C A Pinheiro; F N Pereira-Júnior; M A N Lisboa; G V Cruz; J T Calixto Júnior; A M R Teixeira; H D M Coutinho
Journal:  Toxicol Rep       Date:  2021-03-31

9.  Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells.

Authors:  Elizabeth Grunz-Borgmann; Valeri Mossine; Kevin Fritsche; Alan R Parrish
Journal:  BMC Complement Altern Med       Date:  2015-12-15       Impact factor: 3.659

10.  The Induction of Apoptosis in A375 Malignant Melanoma Cells by Sutherlandia frutescens.

Authors:  Nicola B van der Walt; Zahra Zakeri; Marianne J Cronjé
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.